Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 2;21(1):51.
doi: 10.1186/s12966-024-01601-x.

Longitudinal associations of diurnal rest-activity rhythms with fatigue, insomnia, and health-related quality of life in survivors of colorectal cancer up to 5 years post-treatment

Affiliations

Longitudinal associations of diurnal rest-activity rhythms with fatigue, insomnia, and health-related quality of life in survivors of colorectal cancer up to 5 years post-treatment

Marvin Y Chong et al. Int J Behav Nutr Phys Act. .

Abstract

Background: There is a growing population of survivors of colorectal cancer (CRC). Fatigue and insomnia are common symptoms after CRC, negatively influencing health-related quality of life (HRQoL). Besides increasing physical activity and decreasing sedentary behavior, the timing and patterns of physical activity and rest over the 24-h day (i.e. diurnal rest-activity rhythms) could also play a role in alleviating these symptoms and improving HRQoL. We investigated longitudinal associations of the diurnal rest-activity rhythm (RAR) with fatigue, insomnia, and HRQoL in survivors of CRC.

Methods: In a prospective cohort study among survivors of stage I-III CRC, 5 repeated measurements were performed from 6 weeks up to 5 years post-treatment. Parameters of RAR, including mesor, amplitude, acrophase, circadian quotient, dichotomy index, and 24-h autocorrelation coefficient, were assessed by a custom MATLAB program using data from tri-axial accelerometers worn on the upper thigh for 7 consecutive days. Fatigue, insomnia, and HRQoL were measured by validated questionnaires. Confounder-adjusted linear mixed models were applied to analyze longitudinal associations of RAR with fatigue, insomnia, and HRQoL from 6 weeks until 5 years post-treatment. Additionally, intra-individual and inter-individual associations over time were separated.

Results: Data were available from 289 survivors of CRC. All RAR parameters except for 24-h autocorrelation increased from 6 weeks to 6 months post-treatment, after which they remained relatively stable. A higher mesor, amplitude, circadian quotient, dichotomy index, and 24-h autocorrelation were statistically significantly associated with less fatigue and better HRQoL over time. A higher amplitude and circadian quotient were associated with lower insomnia. Most of these associations appeared driven by both within-person changes over time and between-person differences in RAR parameters. No significant associations were observed for acrophase.

Conclusions: In the first five years after CRC treatment, adhering to a generally more active (mesor) and consistent (24-h autocorrelation) RAR, with a pronounced peak activity (amplitude) and a marked difference between daytime and nighttime activity (dichotomy index) was found to be associated with lower fatigue, lower insomnia, and a better HRQoL. Future intervention studies are needed to investigate if restoring RAR among survivors of CRC could help to alleviate symptoms of fatigue and insomnia while enhancing their HRQoL.

Trial registration: EnCoRe study NL6904 ( https://www.onderzoekmetmensen.nl/ ).

Keywords: Colorectal cancer survivorship; Diurnal rest-activity rhythms; Fatigue; Health-related quality of life; Insomnia.

PubMed Disclaimer

Conflict of interest statement

Judith de Vos-Geelen has served as a consultant for Amgen, AstraZeneca, MSD, Pierre Fabre, and Servier, and has received institutional research funding from Servier, all outside the submitted work. F.A.J.L. Scheer served on the Board of Directors for the Sleep Research Society and has received consulting fees from the University of Alabama at Birmingham and Morehouse School of Medicine. F.A.J.L. Scheer interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. F.A.J.L.S. consultancies are not related to the current work. The other authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram of the inclusion of participants within the Energy for Life after ColoRectal cancer (EnCoRe) study from 2012 onwards and the number of post-treatment measurements available up to October 2021 included in the analyses of the current paper. 1Response rate = (persons with measurements)/(persons with measurements + persons lost to follow-up – persons died). The declining number of participants at subsequent time points is because not all participants included at diagnosis from April 2012 onwards had already reached all follow-up time points by July 2018 (6 weeks until 24 months post-treatment) or October 2021 (60 months post-treatment). 2Since the analyses in this paper were focused on diurnal rest-activity rhythms and fatigue, insomnia, and health-related quality of life (HRQoL) after colorectal cancer treatment, only post-treatment measurements with available data on diurnal rest-activity rhythms, fatigue, insomnia, or HRQoL, and covariates were included. 3Of the three persons without 6 weeks follow-up visits, one person did not have a 6 months follow-up visit before July 16th 2018. Of the six persons without 6 months follow-up visits, one person did not have a 12 months follow-up visit before July 16th 2018. 4All data collected from participants between April 2012 and July 2018 were used for the measurements from 6 weeks until 24 months post-treatment. In addition, these participants were followed over time and data was collected in October 2021 for the 60 months-treatment follow-up measurement
Fig. 2
Fig. 2
Visualization of the operationalized diurnal rest-activity rhythm parameters: mesor, amplitude, acrophase, circadian quotient, dichotomy index, and 24-h autocorrelation coefficient, based on fictitious accelerometer data. A Example of a day the accelerometer was worn by a participant. Activity counts of the participant in each 1-min interval of a 24-h day were available. Based on how these activity counts were distributed across the 24-h day, the best cosine function was fitted according to the following formula: (t)=M+Acos(2πt/T+ϕ)+e(t). In this formula, M is the mesor, A is the amplitude, ϕ is the acrophase, Τ is the period, and e(t) is the error term. For each day the accelerometer was worn, a cosine function was fitted to determine the diurnal rest-activity parameters. Afterwards, these values were averaged across all available accelerometer days. B The dichotomy index was calculated as the percentage of in-bed (I) activity counts, expressed per 1-min interval, that were less than the median of out-of-bed (O) activity counts. The dichotomy index was calculated for each day the accelerometer was worn, and these values were averaged across all available days. C Overlap is shown between two different fictitious days the accelerometer was worn. The 24-h autocorrelation coefficient describes the average correlation between activity counts in 1-min intervals separated by 24 h. For the 24-h autocorrelation coefficient only one value was calculated, as the autocorrelation across all available accelerometer days. In this example, only day 1 and 2 are shown; however, activity counts separated by 24 h between day 2 and day 3, day 3 and 4 etc., are also included in the calculation

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi: 10.3322/caac.21442. - DOI - PubMed
    1. Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol. 2004;22(23):4829–4836. doi: 10.1200/JCO.2004.02.018. - DOI - PubMed
    1. O’Gorman C, Stack J, O’Ceilleachair A, Denieffe S, Gooney M, McKnight M, et al. Colorectal cancer survivors: an investigation of symptom burden and influencing factors. BMC Cancer. 2018;18:1–10. doi: 10.1186/s12885-018-4923-3. - DOI - PMC - PubMed
    1. Howell D, Oliver T, Keller-Olaman S, Davidson J, Garland S, Samuels C, et al. Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice. Ann Oncol. 2014;25(4):791–800. doi: 10.1093/annonc/mdt506. - DOI - PubMed

Publication types